Read Goldman Sachs Boosts Biogen Stock Target Amid New Alzheimer's Strategy MoneyMarkets Goldman Sachs Boosts Biogen Stock Target Amid New Alzheimer's Strategy Goldman Sachs has updated its price target for Biogen, indicating a positive outlook on the company's innovative approach to Alzheimer's treatment. Editorial Staff 29 days ago